Developer docs
API playgroundTry for free, no card

Search company profiles

Future Cardia

Full company profile

uuid0000d9l

Namestring
Future Cardia
Legal namestring
Future Cardia
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTampa, United States
HQ citystring
Tampa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
implantable cardiac monitoring, cardiac arrhythmia detection, heart failure monitoring, multi-sensor cardiac device, remote cardiac monitoring
Industry2 codes
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Implantable Cardiac Monitoring Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Implantable Cardiac Monitoring Device Sales
TypeHardware Sales
Description

Pre-commercial stage. The company is developing an implantable cardiac monitoring device awaiting FDA approval. Revenue will be generated through device sales to healthcare providers and hospitals. The device is positioned as a Class II, 510K device with existing insurance coverage, facilitating reimbursement through healthcare systems.

futurecardia.com
2Remote Monitoring Platform Integration
TypeSubscription Recurring
Description

Partnership with Artella Solutions integrates their remote cardiac monitoring platform with Future Cardia's device, potentially enabling data-driven services and monitoring fees as part of comprehensive cardiac care solutions.

mobihealthnews.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Device pricing not disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Future Cardia is a pre-commercial company with a device awaiting FDA approval. No pricing information is publicly available. The company indicates existing insurance coverage, suggesting reimbursement-based pricing through healthcare systems.

futurecardia.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Future Cardia is developing a single product — the "Voice of the Heart" Cardiac Monitoring System — an implantable, under-the-skin Class II 510(k) cardiac monitor. The device combines four sensors (ECG for heart rhythms, PCG for heart sounds, SCG for cardiac pressure, and an accelerometer for activity) and is implanted in a 2-minute office procedure with a 2-year battery, providing long-term continuous cardiac data for arrhythmia and heart failure patients. It is intended for sale to hospitals and healthcare providers and is currently awaiting FDA approval.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 2-year battery life for long-term monitoring
+2 more records
Product and service1 record
1Voice of the Heart Cardiac Monitoring System
CategoryImplantable Cardiac Monitoring Devices
Description

An implantable, under-the-skin Class II 510(k) cardiac monitoring device combining ECG (heart rhythms), PCG (heart sounds), SCG (cardiac pressure), and accelerometer (activity) sensors. Implanted via a 2-minute office procedure with a 2-year battery, providing continuous long-term cardiac data for arrhythmia and heart failure patients. Sold to hospitals, cardiac care centers, and healthcare providers; supported by existing insurance reimbursement and integration with Artella Solutions' remote monitoring platform.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-11
Description

Future Cardia has expanded its collaboration with Artella Solutions, a remote cardiac monitoring company. The partnership focuses on integrating Artella's monitoring platform with Future Cardia's implantable cardiac monitoring device to enhance data transfer and clinical workflows. This integration aims to provide comprehensive cardiac care solutions.

2StartEngine Primary, LLC
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Reg A+ offering distribution partner for equity crowdfunding. Member FINRA/SIPC. Provides platform for retail investor participation in funding rounds.

futurecardia.com
Peers10 records
TypeEmerging player
Description

Developer of wearable neuromodulation therapy for essential tremor and other conditions, with similar early-stage Class II medical device commercialization dynamics. Less direct overlap but comparable as a small medtech with KOL-driven hospital adoption.

TypeBroad incumbent
Description

Global medtech incumbent with the LINQ insertable cardiac monitor (ICM), the dominant product in implantable cardiac rhythm monitoring. Directly comparable category leader Future Cardia will compete with on electrophysiology hospital sales.

TypeEmerging player
Description

Developer of AI-enabled digital stethoscopes with ECG and heart sound (PCG) capabilities. Comparable in combining ECG + PCG sensor modalities and applying them to cardiac diagnostics, though in a non-implant form factor.

TypeEmerging player
Description

Maker of KardiaMobile personal ECG devices and KardiaNet remote monitoring services. Comparable as an AI-driven ambulatory cardiac monitoring company with recurring monitoring revenue, though focused on consumer/short-term monitoring.

TypeDirect peer
Description

Developer of the Zio long-term cardiac monitoring patch, a competing ambulatory cardiac monitoring solution. Highly comparable as an outpatient cardiac rhythm monitoring company competing for the same electrophysiology prescribing decisions.

TypeDirect peer
Description

European cardiovascular device manufacturer with an insertable cardiac monitor (BioMonitor) in the same Class II category as Future Cardia's device. Closely comparable on product type and hospital/cardiologist customer base.

TypeBroad incumbent
Description

Major cardiac device company with an insertable cardiac monitor and a strong electrophysiology portfolio. Competes for the same hospital and EP lab customers Future Cardia is targeting.

TypeEmerging player
Description

Developer of an implantable left-atrial pressure sensor for heart failure monitoring. Comparable as an early-stage implantable cardiac monitoring startup targeting the same heart failure population and electrophysiology/cardiologist buyers.

TypeEmerging player
Description

Remote cardiac monitoring services company offering BodyGuardian wearable monitors (acquired by Boston Scientific in 2021). Adjacent/emerging competitor in ambulatory cardiac monitoring workflows overlapping with Future Cardia's Artella partnership.

10Abbott
TypeBroad incumbent
Description

Broad incumbent offering the Confirm Rx insertable cardiac monitor plus CardioMEMS for heart failure monitoring. Comparable as a multi-modality cardiac monitoring incumbent with deep electrophysiology relationships.

Market position
Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Future Cardia

Implantable Cardiac Monitoring Devicesfuturecardia.com

Future Cardia firmographics

Firmographics
Name
Future Cardia
Legal name
Future Cardia
Website
https://futurecardia.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Future Cardia industry classification

Industry
Product category
Implantable Cardiac Monitoring Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)

Keywords

  • Implantable cardiac monitoring
  • Cardiac arrhythmia detection
  • Heart failure monitoring
  • Multi-sensor cardiac device
  • Remote cardiac monitoring

Where Future Cardia is headquartered

Location

Headquarters

HQ city
Tampa
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Future Cardia business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Implantable Cardiac Monitoring Device Sales: Pre-commercial stage. The company is developing an implantable cardiac monitoring device awaiting FDA approval. Revenue will be generated through device sales to healthcare providers and hospitals. The device is positioned as a Class II, 510K device with existing insurance coverage, facilitating reimbursement through healthcare systems.
  2. Remote Monitoring Platform Integration: Partnership with Artella Solutions integrates their remote cardiac monitoring platform with Future Cardia's device, potentially enabling data-driven services and monitoring fees as part of comprehensive cardiac care solutions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractDevice pricing not disclosed

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Future Cardia product offering

Product offering

Core offering

Future Cardia is developing a single product — the "Voice of the Heart" Cardiac Monitoring System — an implantable, under-the-skin Class II 510(k) cardiac monitor. The device combines four sensors (ECG for heart rhythms, PCG for heart sounds, SCG for cardiac pressure, and an accelerometer for activity) and is implanted in a 2-minute office procedure with a 2-year battery, providing long-term continuous cardiac data for arrhythmia and heart failure patients. It is intended for sale to hospitals and healthcare providers and is currently awaiting FDA approval.

Differentiator

Problem solved

Functional benefit

Products and services

  • Voice of the Heart Cardiac Monitoring System An implantable, under-the-skin Class II 510(k) cardiac monitoring device combining ECG (heart rhythms), PCG (heart sounds), SCG (cardiac pressure), and accelerometer (activity) sensors. Implanted via a 2-minute office procedure with a 2-year battery, providing continuous long-term cardiac data for arrhythmia and heart failure patients. Sold to hospitals, cardiac care centers, and healthcare providers; supported by existing insurance reimbursement and integration with Artella Solutions' remote monitoring platform.

Quantifiable outcome

  • 2-year battery life for long-term monitoring
  • +2 more outcomes

Companies that use Future Cardia

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Future Cardia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Future Cardia partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Artella SolutionscoreTechnology or Integration · 11 November 2025Future Cardia has expanded its collaboration with Artella Solutions, a remote cardiac monitoring company. The partnership focuses on integrating Artella's monitoring platform with Future Cardia's implantable cardiac monitoring device to enhance data transfer and clinical workflows. This integration aims to provide comprehensive cardiac care solutions.
  • StartEngine Primary, LLCminorChannel Partner/ Reseller/ DistributorReg A+ offering distribution partner for equity crowdfunding. Member FINRA/SIPC. Provides platform for retail investor participation in funding rounds.

Scale indicators5 records

Future Cardia competitors and assessment

Company assessment

Emerging players

  • Cala Health: Developer of wearable neuromodulation therapy for essential tremor and other conditions, with similar early-stage Class II medical device commercialization dynamics. Less direct overlap but comparable as a small medtech with KOL-driven hospital adoption.
  • Eko Health: Developer of AI-enabled digital stethoscopes with ECG and heart sound (PCG) capabilities. Comparable in combining ECG + PCG sensor modalities and applying them to cardiac diagnostics, though in a non-implant form factor.
  • AliveCor: Maker of KardiaMobile personal ECG devices and KardiaNet remote monitoring services. Comparable as an AI-driven ambulatory cardiac monitoring company with recurring monitoring revenue, though focused on consumer/short-term monitoring.
  • Vectorious Medical Technologies: Developer of an implantable left-atrial pressure sensor for heart failure monitoring. Comparable as an early-stage implantable cardiac monitoring startup targeting the same heart failure population and electrophysiology/cardiologist buyers.
  • Preventice Solutions: Remote cardiac monitoring services company offering BodyGuardian wearable monitors (acquired by Boston Scientific in 2021). Adjacent/emerging competitor in ambulatory cardiac monitoring workflows overlapping with Future Cardia's Artella partnership.

Broad incumbents

  • Medtronic: Global medtech incumbent with the LINQ insertable cardiac monitor (ICM), the dominant product in implantable cardiac rhythm monitoring. Directly comparable category leader Future Cardia will compete with on electrophysiology hospital sales.
  • Boston Scientific: Major cardiac device company with an insertable cardiac monitor and a strong electrophysiology portfolio. Competes for the same hospital and EP lab customers Future Cardia is targeting.
  • Abbott: Broad incumbent offering the Confirm Rx insertable cardiac monitor plus CardioMEMS for heart failure monitoring. Comparable as a multi-modality cardiac monitoring incumbent with deep electrophysiology relationships.

Direct peers

  • iRhythm Technologies: Developer of the Zio long-term cardiac monitoring patch, a competing ambulatory cardiac monitoring solution. Highly comparable as an outpatient cardiac rhythm monitoring company competing for the same electrophysiology prescribing decisions.
  • Biotronik: European cardiovascular device manufacturer with an insertable cardiac monitor (BioMonitor) in the same Class II category as Future Cardia's device. Closely comparable on product type and hospital/cardiologist customer base.

Market position

Customer concentration

Future Cardia social profiles

Digital presence

Future Cardia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Future Cardia leadership team

Management profile

Number of profiles

Profiles4 records

Future Cardia funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Future Cardia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Future Cardia

What does Future Cardia do?

Future Cardia is developing a single product — the "Voice of the Heart" Cardiac Monitoring System — an implantable, under-the-skin Class II 510(k) cardiac monitor. The device combines four sensors (ECG for heart rhythms, PCG for heart sounds, SCG for cardiac pressure, and an accelerometer for activity) and is implanted in a 2-minute office procedure with a 2-year battery, providing long-term continuous cardiac data for arrhythmia and heart failure patients. It is intended for sale to hospitals and healthcare providers and is currently awaiting FDA approval.

Is Future Cardia a public or private company?

Future Cardia is a private company. It is classified as venture growth investor backed and is currently operating.

When was Future Cardia founded?

Future Cardia was founded in 2021. It employs 11 to 50 people.

Where is Future Cardia based?

Future Cardia is headquartered in Tampa, United States, in the North America region.

How does Future Cardia make money?

Two revenue lines are on record. Implantable Cardiac Monitoring Device Sales are the primary driver. The others are remote Monitoring Platform Integration.

Who are Future Cardia's main competitors?

Emerging players on record are Cala Health, Eko Health, AliveCor, Vectorious Medical Technologies and Preventice Solutions. Broad incumbents are Medtronic, Boston Scientific and Abbott. Direct peers are iRhythm Technologies and Biotronik.

Does Future Cardia have an API?

No public API is recorded for Future Cardia.

What industry is Future Cardia in?

Future Cardia's product category is Implantable Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLAKABAC, Electrophysiology (Heart Rhythm). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals